LAG3 and Miyoshi myopathy: Importantly, we demonstrated increased LAG3 expression on proliferating CD3+ T cells in MM patient BMMC and PBMC, as well as robust surface and intracellular expression of its ligand, GAL-3, in CD138+ patient MM cells and MM cell lines.